EPISODE · May 11, 2023 · 31 MIN
258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry
from The Readout Loud · host STAT
We discuss a Senate hearing that put major pharma CEOs in the same room with the middlemen they love to blame for rising drug prices, with mixed results. We also explain what is a massive week for Sarepta Therapeutics, the FDA, and the future of gene therapies for rare diseases, plus the latest news in the life sciences.
Embed this episode
NOW PLAYING
258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.